Millendo Therapeutics, Inc. (MLND) Social Stream



Millendo Therapeutics, Inc. (MLND): $15.90

-0.90 (-5.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About MLND

$MLND This is how the merger with Tempest will work. Full details here: https://www.sec.gov/Archives/edgar/data/0001544227/000119312521157780/d150774d424b3.htm

Tempest (a private biotech) is merging with MLND to become a public company. This is an all-share transaction. MLND shareholders are not receiving cash or additional shares in this deal. Tempest shareholders will receive MLND stock. Currently 19m MLND OS. Tempest shareholders will receive over 81m shares of MLND, increasing the OS to over 100 million. At Friday's close MLND market cap was about $20m. After the shares are issued & distributed to Tempest shareholders, the MC will increase to approx $106m.

They will also do a 1:15 reverse split. After the RS, they will exchange all MLND shares for shares of TPST, the new company ticker. 100 million shares of MLND @ $1.06 will become approx 6.7m shares of TPST @ $15.90 after the RS & share exchange.
TwongStocks, published June 27, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 2.252 seconds.